相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Divergent Effects of alpha-Tocopherol and Vitamin C on the Generation of Dysfunctional HDL Associated with Diabetes and the Hp 2-2 Genotype
Rabea Asleh et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Cost-effectiveness of pharmacy and group behavioural support smoking cessation services in Glasgow
Kathleen A. Boyd et al.
ADDICTION (2009)
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Mark J. Pletcher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Vitamin e supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype - A prospective double-blinded clinical trial
Uzi Milman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Haptoglobin genotype - A determinant of cardiovascular complication risk in type 1 diabetes
Tina Costacou et al.
DIABETES (2008)
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype
Rabea Asleh et al.
DIABETES (2008)
Vitamins E and C in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial
Howard D. Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The antioxidant and pro-oxidant activity of vitamin C and trolox in vitro:: a comparative study
Borut Poljsak et al.
JOURNAL OF APPLIED TOXICOLOGY (2008)
Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype implications for the response to intraplaque hemorrhage and plaque vulnerability
Andrew P. Levy et al.
CIRCULATION RESEARCH (2007)
Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque
Andrew P. Levy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo
Rabea Asleh et al.
CIRCULATION RESEARCH (2006)
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction
M Suleiman et al.
DIABETES (2005)
Vitamin E in the primary prevention of cardiovascular disease and cancer - The Women's Health Study: A randomized controlled trial
IM Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20536 individuals
B Mihaylova et al.
LANCET (2005)
Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)
PM Clarke et al.
DIABETOLOGIA (2005)
Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo
R Asleh et al.
CIRCULATION RESEARCH (2005)
Assignment of the binding site for haptoglobin on apolipoprotein A-I
MS Spagnuolo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL
VV Bamm et al.
BIOCHEMISTRY (2004)
The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women
AP Levy et al.
DIABETES CARE (2004)
New aspects in the pathogenesis of diabetic atherothrombosis
PR Moreno et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes
A Roguin et al.
DIABETES CARE (2003)
Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials
DP Vivekananthan et al.
LANCET (2003)
Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease
R Asleh et al.
CIRCULATION RESEARCH (2003)
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The strong heart study
AP Levy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women - A randomized controlled trial
DD Waters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Structure-function analysis of the antioxidant properties of haptoglobin
M Melamed-Frank et al.
BLOOD (2001)
Identification of the haemoglobin scavenger receptor
M Kristiansen et al.
NATURE (2001)
Vitamin E supplementation and cardiovascular events in high-risk patients
S Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
